Comparison

Suplatast (Tosilate) European Partner

Item no. TMO-T0117-100mg
Manufacturer TargetMol
CASRN 94055-76-2
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles CCOCC(COc1ccc(cc1)NC(=O)CC[S+](C)C)O.Cc1ccc(cc1)S(=O)(=O)[O-]
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias IPD 1151T,Suplatast Tosylate,Suplatast tosilate
Similar products 94055-76-2
Shipping Condition Cool pack
Available
Manufacturer - Targets
Interleukin|||IL Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
499.64
Description
Suplatast Tosilate (IPD 1151T) is a novel capsular anti-asthmatic drug with an IC50 above 100 μM, inhibiting both IgE production and the synthesis of IL-4 and IL-5.
Pathways
Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close